Incyte Corporation (INCY)
NASDAQ·Healthcare·Biotechnology
$120.66
+1.85%
Mkt Cap $24.01B
Analyst Ratings
Buy
21
Hold
7
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
Implied Upside
-9.7%
Consensus $108.92 vs current $120.66
NASDAQ·Healthcare·Biotechnology
$120.66
+1.85%
Mkt Cap $24.01B
Buy
21
Hold
7
Sell
0
Price Target (56 analysts)
$108.92
Range $90.00 – $140.00
-9.7%
Consensus $108.92 vs current $120.66